Sort by
Refine Your Search
-
to poor prognosis, it will validate the signature as a biomarker in NSCLC tissues and investigate the therapeutic potential of inducing ferroptosis using a panel of established and novel ferroptosis
Searches related to panel
Enter an email to receive alerts for panel positions